drugset / Trial / NCT05856396

Maternal Determinants of Infant Immunity to Pertussis

NCT05856396

Non-randomizedParallel-groupSingle-blindBasic science

Summary

The overall objective of the project is to identify the determinants of antibody-mediated immunity in infants born to mothers immunized during pregnancy. Using maternal pertussis immunization as a model, the project will identify key predictors and potential determinants of vaccine responses in pregnant women, of the transfer of maternal antibodies to the newborn and of vaccine responses in infants. A systems biology approach will be used to delineate pre-vaccination and post-vaccination cellular and molecular correlates of the immune response to pertussis immunization in peripheral blood and in breastmilk.

Timeline

Start
2023-09-12
Primary completion
2025-12-23
Completion
2025-12-23

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pentacel Vaccine
Comparator Triaxis Vaccine

Indications